MetLife (MET)
Market Price (4/28/2026): $77.96 | Market Cap: $51.3 BilSector: Financials | Industry: Life & Health Insurance
MetLife (MET)
Market Price (4/28/2026): $77.96Market Cap: $51.3 BilSector: FinancialsIndustry: Life & Health Insurance
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 9.6%, Dividend Yield is 3.0%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 5.7%, FCF Yield is 33% Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -192% Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 23%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 23%, CFO LTM is 17 Bil, FCF LTM is 17 Bil Stock buyback supportStock Buyback 3Y Total is 10 Bil Low stock price volatilityVol 12M is 23% Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, Digital & Alternative Assets, AI in Financial Services, and Sustainable Finance. Show more. | Weak multi-year price returns2Y Excs Rtn is -29%, 3Y Excs Rtn is -34% | Key risksMET key risks include [1] short-term accounting losses from its derivative hedging programs during periods of market volatility and [2] negative impacts to its international segments from shifting trade policies. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 9.6%, Dividend Yield is 3.0%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 5.7%, FCF Yield is 33% |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -192% |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 23%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 23%, CFO LTM is 17 Bil, FCF LTM is 17 Bil |
| Stock buyback supportStock Buyback 3Y Total is 10 Bil |
| Low stock price volatilityVol 12M is 23% |
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, Digital & Alternative Assets, AI in Financial Services, and Sustainable Finance. Show more. |
| Weak multi-year price returns2Y Excs Rtn is -29%, 3Y Excs Rtn is -34% |
| Key risksMET key risks include [1] short-term accounting losses from its derivative hedging programs during periods of market volatility and [2] negative impacts to its international segments from shifting trade policies. |
Qualitative Assessment
AI Analysis | Feedback
1. Q4 2025 Revenue Shortfall Driven by Derivative Losses.
Despite exceeding adjusted earnings per share (EPS) expectations with $2.58 in Q4 2025 against an analyst consensus of $2.34 to $2.37, MetLife reported a total revenue of $23.81 billion, which significantly missed analyst estimates of approximately $28.0 billion. This revenue shortfall was primarily attributed to substantial net derivative losses of $646 million, accounting-driven figures that can influence investor perception of underlying financial performance.
2. Mixed Analyst Sentiment and Price Target Revisions.
Following the Q4 2025 earnings report, analyst sentiment included adjustments to price targets that likely contributed to investor uncertainty. For example, Evercore ISI adjusted its price target for MetLife from $97 to $95 after the Q4 results. More recently, in early April 2026, while some firms like UBS raised their targets (e.g., to $102 from $98), others, such as BMO, lowered their price target to $78. This divergence in analyst outlooks and some downward revisions can pressure stock performance.
Show more
Stock Movement Drivers
Fundamental Drivers
The -0.9% change in MET stock from 12/31/2025 to 4/27/2026 was primarily driven by a -17.4% change in the company's Net Income Margin (%).| (LTM values as of) | 12312025 | 4272026 | Change |
|---|---|---|---|
| Stock Price ($) | 78.38 | 77.67 | -0.9% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 70,952 | 75,611 | 6.6% |
| Net Income Margin (%) | 5.4% | 4.5% | -17.4% |
| P/E Multiple | 13.6 | 15.1 | 11.5% |
| Shares Outstanding (Mil) | 665 | 658 | 1.0% |
| Cumulative Contribution | -0.9% |
Market Drivers
12/31/2025 to 4/27/2026| Return | Correlation | |
|---|---|---|
| MET | -0.9% | |
| Market (SPY) | 4.2% | 60.5% |
| Sector (XLF) | -5.4% | 77.4% |
Fundamental Drivers
The -4.3% change in MET stock from 9/30/2025 to 4/27/2026 was primarily driven by a -24.6% change in the company's Net Income Margin (%).| (LTM values as of) | 9302025 | 4272026 | Change |
|---|---|---|---|
| Stock Price ($) | 81.20 | 77.67 | -4.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 72,369 | 75,611 | 4.5% |
| Net Income Margin (%) | 5.9% | 4.5% | -24.6% |
| P/E Multiple | 12.7 | 15.1 | 19.1% |
| Shares Outstanding (Mil) | 671 | 658 | 1.9% |
| Cumulative Contribution | -4.3% |
Market Drivers
9/30/2025 to 4/27/2026| Return | Correlation | |
|---|---|---|
| MET | -4.3% | |
| Market (SPY) | 7.0% | 53.5% |
| Sector (XLF) | -3.5% | 77.9% |
Fundamental Drivers
The -0.4% change in MET stock from 3/31/2025 to 4/27/2026 was primarily driven by a -29.1% change in the company's Net Income Margin (%).| (LTM values as of) | 3312025 | 4272026 | Change |
|---|---|---|---|
| Stock Price ($) | 77.97 | 77.67 | -0.4% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 70,252 | 75,611 | 7.6% |
| Net Income Margin (%) | 6.3% | 4.5% | -29.1% |
| P/E Multiple | 12.2 | 15.1 | 23.9% |
| Shares Outstanding (Mil) | 693 | 658 | 5.3% |
| Cumulative Contribution | -0.4% |
Market Drivers
3/31/2025 to 4/27/2026| Return | Correlation | |
|---|---|---|
| MET | -0.4% | |
| Market (SPY) | 28.1% | 74.6% |
| Sector (XLF) | 5.1% | 85.2% |
Fundamental Drivers
The 47.1% change in MET stock from 3/31/2023 to 4/27/2026 was primarily driven by a 93.2% change in the company's P/E Multiple.| (LTM values as of) | 3312023 | 4272026 | Change |
|---|---|---|---|
| Stock Price ($) | 52.80 | 77.67 | 47.1% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 67,408 | 75,611 | 12.2% |
| Net Income Margin (%) | 7.8% | 4.5% | -43.0% |
| P/E Multiple | 7.8 | 15.1 | 93.2% |
| Shares Outstanding (Mil) | 784 | 658 | 19.1% |
| Cumulative Contribution | 47.1% |
Market Drivers
3/31/2023 to 4/27/2026| Return | Correlation | |
|---|---|---|
| MET | 47.1% | |
| Market (SPY) | 79.8% | 60.9% |
| Sector (XLF) | 68.3% | 79.9% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| MET Return | 37% | 19% | -5% | 28% | -1% | -1% | 94% |
| Peers Return | 45% | 1% | 6% | 17% | 19% | -4% | 105% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 5% | 91% |
Monthly Win Rates [3] | |||||||
| MET Win Rate | 67% | 67% | 58% | 67% | 58% | 25% | |
| Peers Win Rate | 70% | 53% | 55% | 58% | 65% | 45% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 50% | |
Max Drawdowns [4] | |||||||
| MET Max Drawdown | -2% | -6% | -31% | -1% | -16% | -14% | |
| Peers Max Drawdown | -4% | -22% | -23% | -4% | -9% | -13% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -7% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: PRU, AIG, AFL, LNC, PFG. See MET Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 4/27/2026 (YTD)
How Low Can It Go
| Event | MET | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -36.2% | -25.4% |
| % Gain to Breakeven | 56.7% | 34.1% |
| Time to Breakeven | 472 days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -55.2% | -33.9% |
| % Gain to Breakeven | 123.0% | 51.3% |
| Time to Breakeven | 319 days | 148 days |
| 2018 Correction | ||
| % Loss | -31.4% | -19.8% |
| % Gain to Breakeven | 45.7% | 24.7% |
| Time to Breakeven | 785 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -82.9% | -56.8% |
| % Gain to Breakeven | 485.7% | 131.3% |
| Time to Breakeven | 4,437 days | 1,480 days |
Compare to PRU, AIG, AFL, LNC, PFG
In The Past
MetLife's stock fell -36.2% during the 2022 Inflation Shock from a high on 11/25/2022. A -36.2% loss requires a 56.7% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About MetLife (MET)
AI Analysis | Feedback
Think of MetLife as a diversified insurance and financial services giant, similar to Prudential or AIG.
AI Analysis | Feedback
MetLife (MET) provides a diverse range of financial products and services, primarily categorized as follows:
- Life Insurance: Offers individual, group, universal, and variable life policies designed to provide financial protection to beneficiaries.
- Health & Specialty Insurance: Provides a variety of coverages including dental, vision, short- and long-term disability, pet insurance, and long-term care.
- Annuities: Sells fixed, indexed-linked, variable, and institutional income annuities for retirement savings and income generation.
- Employee Benefits Solutions: Delivers services to employers such as prepaid legal plans, administrative services-only arrangements, and funding for postretirement and executive benefit programs.
- Pension Risk Transfers & Structured Settlements: Manages financial risks for defined benefit pension plans and provides guaranteed payment streams for legal settlements.
- Investment & Savings Products: Offers general and separate account products, funding agreements, capital markets investment products, and regular savings products.
AI Analysis | Feedback
MetLife (NYSE: MET) serves a diverse range of customers across its various segments, encompassing both business-to-business (B2B) and business-to-consumer (B2C) operations globally. Due to the vast number of corporate and individual clients, identifying specific "major customer companies" by name is not applicable or publicly disclosed for a financial services provider of this nature. Instead, MetLife's major customers can be most accurately identified by the following categories:
-
Employers and Corporate Clients: This category includes various businesses and organizations of all sizes that purchase MetLife's group insurance products and benefit programs for their employees. These offerings encompass group life, dental, short-and long-term disability, vision, accident & health coverages, and prepaid legal plans. MetLife also provides administrative services-only (ASO) arrangements and solutions for financing nonqualified benefit programs for executives (e.g., company, bank, or trust-owned life insurance).
-
Institutional Clients: This segment consists of pension funds, other financial institutions, and large corporations that utilize MetLife's specialized services. These include pension risk transfers, institutional income annuities, structured settlements, and various capital markets investment products.
-
Individual Consumers: MetLife serves a vast number of individual consumers directly. These customers purchase a wide range of personal insurance and financial products such as whole life, term life, endowments, universal and variable life insurance, individual disability insurance, pet insurance, fixed, indexed-linked, and variable annuities, regular savings products, and protection against long-term healthcare services.
AI Analysis | Feedback
nullAI Analysis | Feedback
Michel A. Khalaf, President and Chief Executive Officer
Michel A. Khalaf became President and CEO of MetLife on May 1, 2019. Prior to this role, he held various senior leadership positions within MetLife across the U.S., Europe, the Middle East, and Africa. Khalaf joined MetLife in 2010 as CEO of the Middle East, Africa and South Asia region following MetLife's acquisition of Alico from AIG. He spent over two decades at American Life Insurance Company (Alico) and its parent, AIG, where he held numerous leadership roles in various international markets, including the Caribbean, France, Italy, Poland, Romania, the Baltics, the Philippines, and Egypt.
John D. McCallion, Executive Vice President and Chief Financial Officer
John D. McCallion is the executive vice president and chief financial officer of MetLife, Inc., and also heads MetLife Investment Management (MIM). He is responsible for all financial management matters, including financial reporting, treasury, corporate actuarial, tax, investor relations, and mergers and acquisitions. McCallion has served as MetLife's CFO since 2018. His previous roles at MetLife include treasurer, chief financial officer of MetLife's EMEA region, and head of investor relations. Before joining MetLife in 2006, he spent 10 years in PricewaterhouseCoopers' insurance audit practice.
Marlene Debel, Executive Vice President, Chief Risk Officer and Head of MetLife Insurance Investments
Marlene Debel is MetLife's chief risk officer and head of MetLife Insurance Investments. She is responsible for monitoring, analyzing, and managing both financial and non-financial risks for the enterprise, and oversees MetLife's general account investment portfolio. Debel joined MetLife in 2011 as executive vice president and treasurer. Her prior roles at MetLife include chief financial officer for the U.S. Business and head of Retirement & Income Solutions. Before joining MetLife, Debel was global head of liquidity risk management and rating agency relations for Bank of America, and assistant treasurer at Merrill Lynch & Co., Inc., where she held various leadership positions in the global treasury department.
Bill Pappas, Executive Vice President and Head of Global Technology and Operations
Bill Pappas serves as the Executive Vice President and Head of Global Technology and Operations for MetLife.
Ramy Tadros, Regional President, U.S. Business and Head of MetLife Holdings
Ramy Tadros is the Regional President of MetLife's U.S. Business and Head of MetLife Holdings. As of September 1, 2023, he began leading MetLife Holdings (MLH).
AI Analysis | Feedback
The key risks to MetLife's business include:
- Interest Rate Fluctuations: MetLife, as a financial services company offering annuities and various insurance products, is significantly exposed to interest rate risk. Fluctuations in interest rates can directly impact the company's net investment income, profitability, and the margins on products like fixed annuities. While higher interest rates can be positive, unexpected or volatile changes can reduce investment income and affect the valuation of its investment portfolio, including its general account assets.
- Intense Competition and Technological Disruption: MetLife operates in a highly competitive global financial services and insurance market. The industry faces continuous pressure from established rivals and new fintech entrants, which employ aggressive pricing strategies, product innovation, and advanced technological integration (such as AI, machine learning, and generative AI) to gain market share. MetLife must continuously adapt to evolving customer needs and invest in digital transformation to maintain its competitive edge.
- Regulatory and Macroeconomic/Geopolitical Risks: The financial services and insurance sectors are subject to extensive and evolving regulatory frameworks, including those related to data privacy, AI ethics, and solvency requirements, which can increase operational costs and impact product offerings. Furthermore, global economic volatility, such as economic downturns, inflation, and labor market shifts, as well as geopolitical instability and changes in international policy (e.g., tariffs), can adversely affect investment valuations, consumer demand for MetLife's products, and overall financial performance. Climate change is also increasingly recognized as a source of regulatory and physical risks that could impact the company's business operations and investments.
AI Analysis | Feedback
Insurtech companies leveraging advanced technologies (such as artificial intelligence and big data analytics) and direct-to-consumer digital platforms pose a clear emerging threat. These companies are streamlining the insurance purchasing process, offering personalized products, providing instant underwriting decisions, and reducing administrative overhead, creating a more convenient and often lower-cost experience for customers. This directly threatens MetLife's traditional distribution channels (agents, brokers), its reliance on legacy IT infrastructure, and its ability to compete on speed, personalization, and cost across segments such as individual life insurance, pet insurance, and certain employee benefits.
AI Analysis | Feedback
MetLife (MET) operates in several large addressable markets globally and within the U.S., offering a diverse range of insurance and financial products. The estimated market sizes for their main products and services are as follows:
Life Insurance
- Global: The global life insurance market was estimated at USD 7.55 trillion in 2024 and is predicted to increase to approximately USD 18.03 trillion by 2034. Other estimates place the global life insurance market at USD 2,765.5 billion in 2022 and USD 3,541.1 billion in 2025, projected to reach USD 4,894.92 billion by 2033.
- U.S.: The U.S. life insurance market size was estimated at USD 1.93 trillion in 2024 and is predicted to be worth around USD 4.74 trillion by 2034. Another report indicated the U.S. life insurance market was valued at USD 765.38 billion in 2023 and is projected to reach USD 1,476.31 billion by 2032.
Annuities
- U.S.: U.S. individual annuity sales rose to an estimated USD 461.3 billion in 2025. The combined U.S. life insurance and annuities market was USD 819 billion in 2024, and is expected to reach USD 1,100.2 billion by 2032. The U.S. annuity market value is also expected to reach USD 388.42 billion by 2029.
Dental Insurance
- Global: The global dental insurance market size was estimated at USD 247 billion in 2025 and is estimated to reach USD 540 billion by 2034. Another estimate places the global market at USD 247.96 billion in 2025, expected to exceed USD 542.99 billion by 2034.
- U.S.: The U.S. dental insurance market size is calculated at USD 97.7 billion in 2025 and is predicted to increase to approximately USD 126.5 billion by 2035. Another source estimated the U.S. dental insurance market size at USD 90.02 billion in 2024, projected to reach around USD 209.46 billion by 2034.
Group Disability Insurance
- U.S.: The U.S. group level disability insurance market size is expected to reach USD 49.31 billion by 2030. The overall U.S. Disability Insurance Market was valued at USD 20.1 billion in 2024. In-force premium for combined long-term disability (LTD), short-term disability (STD), and paid family and medical leave (PFML) in the U.S. was USD 19.9 billion in 2024.
Pet Insurance
- Global: The global pet insurance market size was estimated at USD 21.84 billion in 2025 and is projected to reach USD 79.61 billion by 2033. Another estimate indicates the global market was valued at USD 14.2 billion in 2025, and is expected to grow to USD 46.8 billion in 2035.
- U.S.: The U.S. pet insurance market size was valued at USD 5.34 billion in 2024 and is projected to grow to USD 20.05 billion by 2032. Another source reported the U.S. pet insurance market size at USD 5.11 billion in 2024, projected to reach USD 25.21 billion by 2033.
Long-Term Care Insurance
- Global (Insurance): The global Long Term Care Insurance Market size was USD 32.35 billion in 2024 and is projected to touch USD 45.89 billion by 2032. Another estimate valued the global Long-Term Care Insurance Market Size at USD 24.17 billion in 2023, expecting it to reach USD 89.69 billion by 2033.
- U.S. (Private Insurance): The U.S. long-term care private insurance market size was estimated at USD 9.13 billion in 2022 and is projected to reach USD 14.37 billion by 2030.
- U.S. (Overall Long Term Care Market, including services): The broader U.S. long-term care market size was estimated at USD 503.42 billion in 2025 and is expected to reach USD 937.56 billion by 2033.
AI Analysis | Feedback
MetLife (MET) is expected to drive future revenue growth over the next 2-3 years through several key strategies across its diverse business segments:
- Expansion of Group Benefits in the U.S.: MetLife aims to strengthen its leadership in the U.S. Group Benefits market by expanding its reach to more employers, increasing the number of products offered per employee, and encouraging greater employee participation. This segment generated $25 billion in premiums in 2025 and is targeting an annual growth rate of 4% to 7%.
- Growth in Retirement and Income Solutions, particularly Pension Risk Transfers (PRT): The company plans to capitalize on its unique retirement platforms in the U.S. and Japan through new liability origination and enhanced capital flexibility. The pension risk transfer market is projected for significant growth, with MetLife achieving over $14 billion in PRT sales in 2025, positioning this business as a major engine for increasing fee income and balance sheet scale.
- Acceleration of MetLife Investment Management (MIM): MetLife is focused on accelerating growth within its asset management division by expanding its investment product offerings and capabilities. The acquisition of PineBridge Investments significantly boosted assets under management to $742 billion, up from approximately $600 billion a year prior. MIM is anticipated to achieve approximately 30% revenue growth in 2026 and has a long-term goal of surpassing $1 trillion in assets under management.
- Expansion in High-Growth International Markets (Asia and Latin America): MetLife is prioritizing strategic expansion in high-growth international markets, particularly in Asia and Latin America. This includes leveraging innovative distribution channels and diversifying products to achieve above-market growth. Sales in Asia (excluding Japan) saw a substantial increase in Q1 2025, and Latin America's "MetLife Xcelerator" platform has already attracted 4.5 million customers and generated over $200 million in premiums, fees, and other income in its first year.
- Digital Transformation and AI Integration: The company is making significant investments in digital capabilities and integrating artificial intelligence (AI) to enhance operational efficiency, improve the customer experience, offer personalized advice, and streamline claims processing. This digital transformation is a core element of MetLife's "New Frontier" growth strategy.
AI Analysis | Feedback
Share Repurchases
- MetLife announced a new $3 billion share repurchase authorization on April 30, 2025, which is in addition to approximately $360 million remaining from a previous authorization announced in May 2024.
- The company anticipates common stock repurchases of approximately $2.85 billion for the full year 2025, with similar buyback levels projected for 2026.
- MetLife's annual share buybacks amounted to $2.883 billion in 2025, $3.207 billion in 2024, and $3.103 billion in 2023.
Share Issuance
- MetLife has not made significant share issuances over the last 3-5 years; instead, the number of shares outstanding has consistently declined due to share repurchase programs.
Inbound Investments
- No significant inbound investments made in MetLife by third parties were identified during the last 3-5 years.
Outbound Investments
- MetLife Investment Management completed the acquisition of PineBridge Investments in December 2025 (agreement announced in December 2024) for $1.2 billion, which significantly expanded its assets under management and aligns with MetLife's "New Frontier" strategy to accelerate growth in asset management.
- In January 2025, MetLife Investment Management agreed to acquire three portfolio management teams and approximately $6 billion in assets under management from Mesirow, bolstering its capabilities in high yield, bank loan, strategic fixed income, and small-cap value.
- In the third quarter of 2025, MetLife executed a $10 billion variable annuity risk transfer to Talcott Resolution Life Insurance Company, a strategic move aimed at managing risk and reducing its retail variable annuity tail risk by about 40%.
Capital Expenditures
- MetLife earmarked approximately $4 billion for organic growth initiatives in 2025 and an additional $1 billion to support mergers and acquisitions, including the PineBridge Investments acquisition.
- The company's "New Frontier" strategy, launched in late 2024, emphasizes strategic investments in accelerating growth within asset management, expanding group benefits insurance, enhancing its retirement platform, and fostering growth in international markets.
- MetLife allocated approximately $1.2 billion towards acquisitions and other business investments in 2025.
Latest Trefis Analyses
Trade Ideas
Select ideas related to MET.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 03312026 | HBAN | Huntington Bancshares | Insider | Insider Buys 45DStrong Insider BuyingCompanies with multiple insider buys in the last 45 days | 0.0% | 0.0% | 0.0% |
| 03312026 | NP | Neptune Insurance | Insider | Insider Buys 45DStrong Insider BuyingCompanies with multiple insider buys in the last 45 days | 0.0% | 0.0% | 0.0% |
| 03272026 | JKHY | Jack Henry & Associates | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | 3.1% | 3.1% | 0.0% |
| 03202026 | MKTX | MarketAxess | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -5.2% | -5.2% | -5.7% |
| 03202026 | RYAN | Ryan Specialty | Insider | Insider Buys | Low D/EStrong Insider BuyingCompanies with strong insider buying in the last 1 month, positive operating income and reasonable debt / market cap | -2.7% | -2.7% | -8.5% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 86.63 |
| Mkt Cap | 36.7 |
| Rev LTM | 22,558 |
| Op Inc LTM | - |
| FCF LTM | 3,876 |
| FCF 3Y Avg | 4,249 |
| CFO LTM | 3,925 |
| CFO 3Y Avg | 4,294 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | -2.5% |
| Rev Chg 3Y Avg | 0.8% |
| Rev Chg Q | -3.0% |
| QoQ Delta Rev Chg LTM | -0.9% |
| Op Inc Chg LTM | - |
| Op Inc Chg 3Y Avg | - |
| Op Mgn LTM | - |
| Op Mgn 3Y Avg | - |
| QoQ Delta Op Mgn LTM | - |
| CFO/Rev LTM | 13.5% |
| CFO/Rev 3Y Avg | 14.9% |
| FCF/Rev LTM | 13.5% |
| FCF/Rev 3Y Avg | 14.9% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 36.7 |
| P/S | 1.0 |
| P/Op Inc | - |
| P/EBIT | 9.4 |
| P/E | 14.0 |
| P/CFO | 5.1 |
| Total Yield | 9.9% |
| Dividend Yield | 3.0% |
| FCF Yield 3Y Avg | 13.5% |
| D/E | 0.3 |
| Net D/E | -1.4 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 9.6% |
| 3M Rtn | 1.2% |
| 6M Rtn | -2.0% |
| 12M Rtn | 7.5% |
| 3Y Rtn | 49.1% |
| 1M Excs Rtn | -4.7% |
| 3M Excs Rtn | -2.0% |
| 6M Excs Rtn | -7.2% |
| 12M Excs Rtn | -24.4% |
| 3Y Excs Rtn | -24.9% |
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Group Benefits | 26,122 | 25,230 | 24,402 | ||
| Retirement and Income Solutions (RIS) | 17,076 | 16,635 | 20,518 | ||
| Asia | 11,415 | 10,926 | 11,255 | 13,360 | |
| Latin America | 7,586 | 7,371 | 6,031 | 5,030 | |
| Revenues attributed to business activities within Corporate & Other | 7,357 | ||||
| Europe, the Middle East, and Africa (EMEA) | 2,770 | 2,543 | 2,441 | 2,928 | |
| Unit-linked investment income | 1,091 | ||||
| MetLife Investment Management, the Company’s institutional asset management business (MIM) | 725 | ||||
| Other | 224 | 791 | |||
| Reinsurance activity | 31 | ||||
| Investment hedge adjustments | -604 | -1,012 | |||
| Net investment gains (losses) | -1,184 | -2,824 | |||
| Net derivative gains (losses) | -1,623 | -2,140 | |||
| MetLife Holdings | 8,202 | 9,037 | 11,141 | ||
| Unit-linked investment income and Reinsurance adjustments | 1,183 | ||||
| Corporate & Other | 655 | 701 | |||
| Reinsurance adjustments | -5,569 | 836 | |||
| United States (U.S.) | 37,084 | ||||
| Total | 70,986 | 66,905 | 68,770 | 71,080 |
Price Behavior
| Market Price | $77.67 | |
| Market Cap ($ Bil) | 51.1 | |
| First Trading Date | 04/05/2000 | |
| Distance from 52W High | -5.3% | |
| 50 Days | 200 Days | |
| DMA Price | $73.26 | $76.66 |
| DMA Trend | indeterminate | down |
| Distance from DMA | 6.0% | 1.3% |
| 3M | 1YR | |
| Volatility | 27.4% | 23.1% |
| Downside Capture | 0.68 | 0.63 |
| Upside Capture | 101.75 | 88.09 |
| Correlation (SPY) | 64.6% | 57.3% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 0.72 | 1.06 | 0.99 | 0.86 | 1.10 | 1.01 |
| Up Beta | -0.43 | 0.13 | 0.70 | 0.47 | 0.98 | 0.94 |
| Down Beta | 0.53 | 1.26 | 1.14 | 1.03 | 1.34 | 1.28 |
| Up Capture | 101% | 104% | 77% | 65% | 86% | 70% |
| Bmk +ve Days | 7 | 16 | 27 | 65 | 139 | 424 |
| Stock +ve Days | 10 | 21 | 29 | 59 | 134 | 408 |
| Down Capture | 75% | 119% | 113% | 102% | 113% | 98% |
| Bmk -ve Days | 12 | 23 | 33 | 58 | 110 | 323 |
| Stock -ve Days | 12 | 21 | 34 | 67 | 118 | 340 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with MET | |
|---|---|---|---|---|
| MET | 5.5% | 23.1% | 0.16 | - |
| Sector ETF (XLF) | 8.5% | 14.7% | 0.34 | 77.0% |
| Equity (SPY) | 31.2% | 12.5% | 1.91 | 57.7% |
| Gold (GLD) | 39.7% | 27.2% | 1.21 | -3.6% |
| Commodities (DBC) | 45.1% | 18.1% | 1.93 | -12.0% |
| Real Estate (VNQ) | 13.1% | 13.4% | 0.67 | 40.1% |
| Bitcoin (BTCUSD) | -17.7% | 42.1% | -0.35 | 23.7% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with MET | |
|---|---|---|---|---|
| MET | 8.1% | 25.7% | 0.30 | - |
| Sector ETF (XLF) | 10.2% | 18.7% | 0.42 | 82.3% |
| Equity (SPY) | 12.9% | 17.1% | 0.59 | 62.2% |
| Gold (GLD) | 20.9% | 17.8% | 0.96 | -1.0% |
| Commodities (DBC) | 14.5% | 19.1% | 0.62 | 18.1% |
| Real Estate (VNQ) | 3.4% | 18.8% | 0.08 | 48.9% |
| Bitcoin (BTCUSD) | 6.5% | 56.3% | 0.33 | 20.5% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with MET | |
|---|---|---|---|---|
| MET | 10.5% | 30.4% | 0.39 | - |
| Sector ETF (XLF) | 12.7% | 22.2% | 0.53 | 86.1% |
| Equity (SPY) | 14.8% | 17.9% | 0.71 | 69.4% |
| Gold (GLD) | 13.8% | 15.9% | 0.72 | -6.3% |
| Commodities (DBC) | 10.0% | 17.8% | 0.47 | 27.0% |
| Real Estate (VNQ) | 5.3% | 20.7% | 0.22 | 54.1% |
| Bitcoin (BTCUSD) | 68.2% | 66.9% | 1.07 | 16.5% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 2/4/2026 | -3.4% | 1.1% | -7.9% |
| 11/5/2025 | -3.4% | 1.9% | -0.8% |
| 8/6/2025 | -2.8% | 1.9% | 4.7% |
| 4/30/2025 | 0.5% | 2.6% | 5.0% |
| 2/5/2025 | -1.6% | -2.7% | -3.2% |
| 10/30/2024 | -5.7% | 0.8% | 6.8% |
| 7/31/2024 | -1.4% | -9.8% | 0.7% |
| 5/1/2024 | -2.3% | 0.5% | 1.5% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 9 | 14 | 16 |
| # Negative | 15 | 10 | 8 |
| Median Positive | 2.4% | 2.2% | 3.7% |
| Median Negative | -2.3% | -2.6% | -7.0% |
| Max Positive | 6.1% | 16.7% | 25.3% |
| Max Negative | -7.8% | -10.9% | -9.2% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 12/31/2025 | 02/19/2026 | 10-K |
| 09/30/2025 | 11/07/2025 | 10-Q |
| 06/30/2025 | 08/07/2025 | 10-Q |
| 03/31/2025 | 05/01/2025 | 10-Q |
| 12/31/2024 | 02/21/2025 | 10-K |
| 09/30/2024 | 11/01/2024 | 10-Q |
| 06/30/2024 | 08/01/2024 | 10-Q |
| 03/31/2024 | 05/02/2024 | 10-Q |
| 12/31/2023 | 02/16/2024 | 10-K |
| 09/30/2023 | 11/02/2023 | 10-Q |
| 06/30/2023 | 08/04/2023 | 10-Q |
| 03/31/2023 | 05/04/2023 | 10-Q |
| 12/31/2022 | 02/23/2023 | 10-K |
| 09/30/2022 | 11/03/2022 | 10-Q |
| 06/30/2022 | 08/04/2022 | 10-Q |
| 03/31/2022 | 05/05/2022 | 10-Q |
Recent Forward Guidance [BETA]
Latest: Q4 2025 Earnings Reported 2/4/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2025 U.S. Statutory Adjusted Capital | 17.20 Bil | 0.6% | Higher New | Actual: 17.10 Bil for 2025 | |||
| 2025 Japan Solvency Margin Ratio | 770.0% | 4.1% | Higher New | Actual: 740.0% for 2025 | |||
Insider Activity
Expand for More| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Pappas, Bill | EVP, Global Tech. & Ops. | Direct | Sell | 5132025 | 80.49 | 26,000 | 2,092,683 | 5,372,078 | Form |
Industry Resources
| Financials Resources |
| Federal Reserve Economic Data |
| Federal Reserve |
| FDIC Data |
| American Banker |
| The Banker |
| Banking Technology |
| Life & Health Insurance Resources |
| Insurance Business America |
| A.M. Best |
| National Underwriter |
| Insurance News |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.